|
Name |
Trichodermic acid A
|
Molecular Formula | C19H28O4 | |
IUPAC Name* |
(2E,4E)-5-[(1S,2S,4aR,6S,7R,8S,8aS)-7-hydroxy-6-(hydroxymethyl)-2,8-dimethyl-1,2,4a,5,6,7,8,8a-octahydronaphthalen-1-yl]-2-methylpenta-2,4-dienoic acid
|
|
SMILES |
C[C@H]1C=C[C@H]2C[C@H]([C@@H]([C@H]([C@@H]2[C@H]1/C=C/C=C(\C)/C(=O)O)C)O)CO
|
|
InChI |
InChI=1S/C19H28O4/c1-11-7-8-14-9-15(10-20)18(21)13(3)17(14)16(11)6-4-5-12(2)19(22)23/h4-8,11,13-18,20-21H,9-10H2,1-3H3,(H,22,23)/b6-4+,12-5+/t11-,13-,14-,15-,16-,17-,18+/m0/s1
|
|
InChIKey |
HOZHXCYISCFSFQ-PFVFAAEOSA-N
|
|
Synonyms |
Tricodermic acid A; Trichodermic acid A
|
|
CAS | NA | |
PubChem CID | 101583709 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 320.4 | ALogp: | 3.3 |
HBD: | 3 | HBA: | 4 |
Rotatable Bonds: | 4 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 77.8 | Aromatic Rings: | 2 |
Heavy Atoms: | 23 | QED Weighted: | 0.421 |
Caco-2 Permeability: | -4.981 | MDCK Permeability: | 0.00006690 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0.052 |
Human Intestinal Absorption (HIA): | 0.884 | 20% Bioavailability (F20%): | 0.015 |
30% Bioavailability (F30%): | 0.032 |
Blood-Brain-Barrier Penetration (BBB): | 0.928 | Plasma Protein Binding (PPB): | 81.99% |
Volume Distribution (VD): | 0.802 | Fu: | 10.67% |
CYP1A2-inhibitor: | 0.083 | CYP1A2-substrate: | 0.112 |
CYP2C19-inhibitor: | 0.021 | CYP2C19-substrate: | 0.629 |
CYP2C9-inhibitor: | 0.021 | CYP2C9-substrate: | 0.287 |
CYP2D6-inhibitor: | 0.006 | CYP2D6-substrate: | 0.123 |
CYP3A4-inhibitor: | 0.051 | CYP3A4-substrate: | 0.157 |
Clearance (CL): | 1.544 | Half-life (T1/2): | 0.916 |
hERG Blockers: | 0.039 | Human Hepatotoxicity (H-HT): | 0.705 |
Drug-inuced Liver Injury (DILI): | 0.797 | AMES Toxicity: | 0.01 |
Rat Oral Acute Toxicity: | 0.823 | Maximum Recommended Daily Dose: | 0.058 |
Skin Sensitization: | 0.407 | Carcinogencity: | 0.153 |
Eye Corrosion: | 0.044 | Eye Irritation: | 0.529 |
Respiratory Toxicity: | 0.952 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC006079 | 0.779 | D0E9KA | 0.231 | ||||
ENC006077 | 0.662 | D05ZYM | 0.217 | ||||
ENC006078 | 0.506 | D02HYK | 0.213 | ||||
ENC003167 | 0.500 | D0F1EX | 0.212 | ||||
ENC004696 | 0.307 | D02RQU | 0.212 | ||||
ENC002015 | 0.296 | D06WTZ | 0.203 | ||||
ENC002817 | 0.289 | D03IKT | 0.202 | ||||
ENC003292 | 0.270 | D0X7XG | 0.201 | ||||
ENC003781 | 0.270 | D0H0ND | 0.200 | ||||
ENC003293 | 0.266 | D05ZTH | 0.196 |